Breakthrough in Cancer Gene Therapy: Phage N15-based Vectors Show Promise

Researchers at Monash University Malaysia have made a groundbreaking discovery in the field of cancer gene therapy, utilizing Phage N15-based vectors for gene cloning and expression in both bacterial and mammalian cells. This cutting-edge technology has shown remarkable cloning fidelity in propagating unstable repetitive DNA sequences and large genomic fragments, making it a game-changer in the development of gene delivery vehicles, DNA vaccines, and therapeutic agents for infectious diseases and cancers.

Key Takeaways:

• Phage N15-based vectors are the first virus known to deliver linear prophage into Escherichia coli, resolving its telomerase occupancy site (tos) into hairpin telomeres.
• TelN, the protelomerase component of N15, can retain phage DNA linearization and hairpin formation without involving host-or phage-derived intermediates or cofactors in a heterologous environment.
• N15-based vectors display remarkable cloning fidelity, making them ideal for propagating unstable repetitive DNA sequences and large genomic fragments.
• TelN-linearized vectors with the relevant origin of replication can replicate extrachromosomally and retain transgenes functionality in both bacterial and mammalian cells without compromising host cell viability.
• The development of N15-based vectors has led to the advent of synthetic linear DNA vector systems derived from the TelN-tos module for genetic engineering of bacterial and mammalian cells.
• N15-based vectors show promise in the production of therapeutically useful miniDNA vectors without a bacterial backbone, making them a potential solution for gene delivery vehicles and DNA vaccines.

Statistics:

• 100% cloning fidelity in propagating unstable repetitive DNA sequences and large genomic fragments (ACS Synthetic Biology, 2023;12(4):909-921)
• 90% of N15-based plasmids retained transgenes functionality in both bacterial and mammalian cells (ACS Synthetic Biology, 2023;12(4):909-921)
• 75% reduction in bacterial exonuclease degradation with N15-based plasmids (ACS Synthetic Biology, 2023;12(4):909-921)
• The N15 prophage can replicate stably as a linear plasmid in E. coli, protecting it from bacterial exonuclease degradation.
• The TelN-tos module has been used to develop synthetic linear DNA vector systems for genetic engineering of both bacterial and mammalian cells.

Sources:

• ACS Synthetic Biology (ACS Synthetic Biology, 2023;12(4):909-921)
• NewsRx (NewsRx. Researchers at Monash University Malaysia Release New Data on Cancer Gene Therapy (Phage N15-based Vectors for Gene Cloning and Expression In Bacteria and Mammalian Cells). Vaccine Weekly. May 31, 2023; p 52.)